Doubling Michigan's vaccine supply could prevent 1,200 deaths, model suggests

www.dailymail.co.uk
9 min read
standard
Biden administration officials are refusing to boost the vaccine supply sent to Michigan, which is now in a vicious fourth wave of coronavirus infections and deaths.
Doubling the number of doses sent to the Great Lakes state weekly could prevent up to 1,200 COVID-19 deaths, one University of California, Berkeley model suggests.

But when asked about altering the federal government's vaccine allocation plan, senior White House Covid adviser Andy Slavitt said: 'By and large, we are still allocating vaccines based upon population.'

That's the same strategy the government has employed to distribute vaccines throughout the majority of the rollout, and the team of advisers is sticking stubbornly to it despite the growing crisis in Michigan.

'I would be surging a lot of vaccines to Michigan right now,' Dr Ashish Jha, the dean of the Brown University School of Public Health told Stat News.

Meanwhile, the federal government has lowered vaccine-supply allotments for Washington, apparently because of problems at a facility producing Johnson & Johnson vaccine, Washington state health officials said Wednesday.

Doubling the number of doses sent to the Great Lakes state weekly could prevent up to 1,200 COVID-19 deaths (green), one University of California, Berkeley model suggests. Combining a vaccine surge supply and putting reopenings on pause could prevent 2,500 deaths (orange)

Senior White House Covid adviser Andy Slavitt said: 'By and large, we are still allocating vaccines based upon population,' rather than adjusting allocations to account for case surges like Michigan's

A Baltimore, Maryland facility making Johnson & Johnson's vaccine mixed up an ingredient for it with one intended for the AstraZeneca vaccine (which was also being manufactured there at the time), ruining a batch of 15 million doses of the J&J shot.

Comments about the decreased supply Wednesday come as state health officials prepare to open vaccine eligibility on April 15 to everyone age 16 and over, The Seattle Times reported.

Taken together, the series of fumbles raise questions about how well federal U.S. officials are responding in real time to the constant…
Natalie Rahhal U.S., Mary Kekatos Senior, Ap, By Natalie Rahhal U.S. Health Editor Mary Kekatos Senior Health Reporter Ap
Read full article